Literature DB >> 29674320

Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.

Yi-Ming Chen1,2,3, Tsai-Ling Liao1,2, Hsin-Hua Chen1,2,3, Der-Yuan Chen4,5,6.   

Abstract

Entities:  

Keywords:  dmards (biologic); rheumatoid arthritis; tuberculosis

Mesh：

Substances：

Year:  2018        PMID： 29674320     DOI： 10.1136/annrheumdis-2018-213097

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

Review 1.  Assessment of latent infections in patients receiving biological therapies.

Authors:  M Fernández-Ruiz
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

2.  Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients.

Authors:  Ping-Huai Wang; Chou-Han Lin; Ting-Hui Chang; Chien-Sheng Wu
Journal:  BMC Pulm Med       Date:  2020-08-31       Impact factor: 3.317

3.  Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study.

Authors:  Hung-Ling Huang; Wei-Chang Huang; Kun-Der Lin; Shin-Shin Liu; Meng-Rui Lee; Meng-Hsuan Cheng; Chun-Shih Chin; Po-Liang Lu; Chau-Chyun Sheu; Jann-Yuan Wang; I-Te Lee; Inn-Wen Chong
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.